LABCORP
LIVE

Serial Number

90687165

Owner

LABORATORY CORPORATION OF AMERICA HOLDINGS

Attorney

William M. Bryner

First Use Date

Jan 2, 2021

Filing Date

May 3, 2021

Add to watchlist:

No watchlists yet
View on USPTO

LABCORP Trademark

Serial Number: 90687165 • Registration: 7795684

LABCORP is a trademark filed by LABORATORY CORPORATION OF AMERICA HOLDINGS on May 3, 2021. The trademark is classified under Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 35 (Advertising & Business). The application is currently registered and active.

Owner Contact Info

LABORATORY CORPORATION OF AMERICA HOLDINGS (343 trademarks)

531 SOUTH SPRING STREET
BURLINGTON, NC 27215

Entity Type: 03

Trademark Details

Filing Date

May 3, 2021

Registration Date

May 13, 2025

First Use Anywhere

January 2, 2021

First Use in Commerce

January 2, 2021

Published for Opposition

February 7, 2023

Goods & Services

Business management and management consulting services in connection with the provision of clinical, diagnostic and analytical testing services; regulatory submission management, namely, assisting others in preparing and filing applications with governmental regulatory bodies for approval of new drugs and medical devices; economic forecasting of drug supplies for clinical trials; recruiting patients and volunteers for clinical trials; business administration of patient reimbursement programs; market research, data collection into computer databases, database management, and business project management services, all in the fields of medical testing, diagnostic testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology

medical testing for diagnostic, treatment, or screening purposes; medical testing for forensic diagnostic purposes; genetic testing for medical purposes; consulting services in the fields of medical testing, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care and healthcare

Diagnostic test kits for medical use comprised of devices for collecting bodily fluid samples, namely, collection tubes, lancets, swabs, probes and collection envelopes, all for the purpose of medical diagnostic testing and treatment

pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemical; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of conducting clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; providing online computer databases featuring information in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemical; providing temporary use of non-downloadable software through a web-based portal to collect, organize, and report medical information, medical records, and diagnostic testing records; providing a web-based portal in the fields of medical testing for scientific research purposes, testing for quality control purposes, genetic testing for scientific research purposes, and medical and scientific research in the field of, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; temporary computer information storage and retrieval in the field of clinical, diagnostic and analytical testing

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 13, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
May 13, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Apr 21, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Apr 21, 2025 CNPR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 4, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 4, 2025 CRFA
ASSIGNED TO LIE
Apr 4, 2025 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 19, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 6, 2025 GNRN
NON-FINAL ACTION E-MAILED
Jan 6, 2025 GNRT
SU - NON-FINAL ACTION - WRITTEN
Jan 6, 2025 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Dec 18, 2024 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 17, 2024 AITU
USE AMENDMENT FILED
Oct 4, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 4, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2024 EXRA
SOU EXTENSION 3 GRANTED
Oct 4, 2024 EX3G
SOU EXTENSION 3 FILED
Oct 4, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 4, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 3, 2024 EXRA
SOU EXTENSION 2 GRANTED
Apr 2, 2024 EX2G
SOU EXTENSION 2 FILED
Apr 2, 2024 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 2, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 5, 2023 EXRA
SOU EXTENSION 1 GRANTED
Oct 3, 2023 EX1G
SOU EXTENSION 1 FILED
Oct 3, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Oct 3, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 4, 2023 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 18, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 3, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 12, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Dec 11, 2022 ERFR
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
Nov 28, 2022 GNS1
CONTINUATION OF FINAL REFUSAL E-MAILED
Nov 28, 2022 GNCF
ACTION CONTINUING A FINAL - COMPLETED
Nov 28, 2022 CNCF
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 8, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 8, 2022 CRFA
TEAS REQUEST FOR RECONSIDERATION RECEIVED
Nov 8, 2022 ERFR
NOTIFICATION OF FINAL REFUSAL EMAILED
May 12, 2022 GNFN
FINAL REFUSAL E-MAILED
May 12, 2022 GNFR
FINAL REFUSAL WRITTEN
May 12, 2022 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 26, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 26, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 26, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Oct 27, 2021 GNRN
NON-FINAL ACTION E-MAILED
Oct 27, 2021 GNRT
NON-FINAL ACTION WRITTEN
Oct 27, 2021 CNRT
ASSIGNED TO EXAMINER
Oct 20, 2021 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 6, 2021 MDSM
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 5, 2021 NWOS
NEW APPLICATION ENTERED
May 6, 2021 NWAP